Scholarlink

Background <p>The clinical spectrum of autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) in Asian populations remains incompletely defined. We aimed to characterize the clinical, radiological, and genetic features of Japanese patients with ARSACS and to expand the mutational and phenotypic spectrum of this disorder.</p> Methods <p>We conducted a retrospective case series of patients diagnosed with ARSACS in our department between January 2016 and December 2023. Five patients from four families with biallelic <i>SACS</i> variants were identified.</p> Results <p>Genetic analysis revealed seven pathogenic <i>SACS</i> variants, of which six were novel. Clinical heterogeneity was notable, with age at onset ranging from 1 to 27 years. Four patients showed classical ARSACS-related neuroimaging findings, whereas one patient presented with a Charcot–Marie–Tooth disease (CMT)-mimicking phenotype characterized by predominant peripheral neuropathy, mild cerebellar involvement, and absence of the classical pontocerebellar magnetic resonance imaging features.</p> Conclusions <p>The recognition of CMT-mimicking presentations supports considering ARSACS in the differential diagnosis of hereditary peripheral neuropathies, particularly in patients with additional cerebellar, pyramidal, or supportive neuroimaging features.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Six novel SACS mutations expand the autosomal recessive spastic ataxia of Charlevoix–Saguenay spectrum

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月1日

查看全文
  • Susumu Ikenoshita,
  • Toshiya Nomura,
  • Haruo Shimazaki,
  • Hiroyuki Uetani,
  • Keiichi Nakahara,
  • Takahiro Okazaki,
  • Michie Imamura,
  • Hironori Mizutani,
  • Aoi Fudo,
  • Yuya Jo,
  • Soichiro Matsubara,
  • Yujiro Higuchi,
  • Toshinori Hirai,
  • Hiroshi Takashima,
  • Mitsuharu Ueda

摘要

Background

The clinical spectrum of autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) in Asian populations remains incompletely defined. We aimed to characterize the clinical, radiological, and genetic features of Japanese patients with ARSACS and to expand the mutational and phenotypic spectrum of this disorder.

Methods

We conducted a retrospective case series of patients diagnosed with ARSACS in our department between January 2016 and December 2023. Five patients from four families with biallelic SACS variants were identified.

Results

Genetic analysis revealed seven pathogenic SACS variants, of which six were novel. Clinical heterogeneity was notable, with age at onset ranging from 1 to 27 years. Four patients showed classical ARSACS-related neuroimaging findings, whereas one patient presented with a Charcot–Marie–Tooth disease (CMT)-mimicking phenotype characterized by predominant peripheral neuropathy, mild cerebellar involvement, and absence of the classical pontocerebellar magnetic resonance imaging features.

Conclusions

The recognition of CMT-mimicking presentations supports considering ARSACS in the differential diagnosis of hereditary peripheral neuropathies, particularly in patients with additional cerebellar, pyramidal, or supportive neuroimaging features.